Kamiza, Abram B.
Toure, Sounkou M.
Vujkovic, Marijana http://orcid.org/0000-0003-4924-5714
Machipisa, Tafadzwa http://orcid.org/0000-0002-4882-9067
Soremekun, Opeyemi S.
Kintu, Christopher
Corpas, Manuel http://orcid.org/0000-0002-4417-1018
Pirie, Fraser
Young, Elizabeth
Gill, Dipender http://orcid.org/0000-0001-7312-7078
Sandhu, Manjinder S.
Kaleebu, Pontiano
Nyirenda, Moffat http://orcid.org/0000-0003-2120-4806
Motala, Ayesha A.
Chikowore, Tinashe http://orcid.org/0000-0002-6743-751X
Fatumo, Segun http://orcid.org/0000-0003-4525-3362
Funding for this research was provided by:
Wellcome Trust (220740/Z/20/Z)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (1U01HG011717, 1U01HG011717)
Article History
Received: 18 August 2021
Accepted: 20 April 2022
First Online: 2 June 2022
Competing interests
: D.G. is employed part-time by Novo Nordisk. At the time of writing, M.C. is associated with Cambridge Precision Medicine Limited, UK. All other authors have no competing interests.